Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues

Journal of Histochemistry and Cytochemistry

Volumn 54, Issue 4, 2006, Pages 385-395

  Pusztaszeri, Marc P ^a   Seelentag, Walter ^a   Bosman, Fred T ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

CD34; Endothelial cells; Fli 1; Heterogeneity; Microvasculature; Platelet endothelial cell adhesion molecule 1; Von Willebrand factor

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; PROTEIN FLI1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ARTICLE; AUTOPSY; BIOPSY; BLOOD VESSEL; CAPILLARY WALL; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY; LIVER SINUSOID; LUNG ALVEOLUS; LYMPH VESSEL ENDOTHELIUM; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN;

ANTIGENS, CD31; ANTIGENS, CD34; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; ENDOTHELIUM, LYMPHATIC; ENDOTHELIUM, VASCULAR; GELSOLIN; HUMANS; IMMUNOHISTOCHEMISTRY; MICROFILAMENT PROTEINS; ORGAN SPECIFICITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; VON WILLEBRAND FACTOR;

EID: 33645123097     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6514.2005     Document Type: Article

References (41)

1. Alles JU, Bosslet K (1988) Immunohistochemistry of angiosarcomas. A study of 19 cases with special emphasis on the applicability of endothelial cell specific markers to routinely prepared tissues. Am J Clin Pathol 89:463-471
2. Ben-Izhak O, Bejar J, Ben-Eliezer S, Vlodavsky E (2001) Splenic littoral cell haemangioendothelioma: a new low-grade variant of malignant littoral cell tumour. Histopathology 39:469-475
3. Carvalho AC, Bellman SM, Saullo VJ, Quinn D, Zapol WM (1982) Altered factor VIII in acute respiratory failure. N Engl J Med 307:1113-1119
4. Carreira C, Nasser SM, di Tomaso E, Padera TP, Boucher Y, Tomarev SI, Jain RK (2001) LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 61:8079-8084
5. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, et al. (1998) Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91:3527-3561
6. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, et al. (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677
7. De Young BR, Wick MR, Fitzgibbon JF, Sirgi KE, Swanson PE (1993) CD31: an immuno-specific marker for endothelial differentiation in human neoplasms. Appl Immunohistochem 1:97-100
8. De Young BR, Frierson HF Jr, Ly MN, Smith D, Swanson PE (1998) CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 110:374-377
9. Di Carlo I, Fraggetta F, Lombardo R, Azzarello G, Vasquez E, Puleo S (2002) CD 34 expression in chronic and neoplastic liver diseases. Panminerva Med 44:365-367
10. Fleming S, Jones DB (1989) Antigenic heterogeneity of renal endothelium. J Pathol 158:319-323
11. Folpe AL, Chand EM, Goldblum JR, Weiss SW (2001) Expression of Fli-1, a nuclear transcription factor, distinguishes vascular neoplasms from potential mimics. Am J Surg Pathol 25:1061-1066
12. Fukunaga M (2005) Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 46:396-402
13. Gorog DA, Rakhit R, Parums D, Laffan M, Davies GJ (1998) Raised factor VIII is associated with coronary thrombotic events. Heart 80:415-417
14. Hewett PW, Nishi K, Daft EL, Clifford Murray J (2001) Selective expression of erg isoforms in human endothelial cells. Int J Biochem Cell Biol 33:347-355
15. Kahaleh MB, Osborn I, LeRoy EC (1981) Increased factor VIII/von Willebrand factor antigen and von Willebrand activity in scleroderma and Raynaud's phenomenon. Ann Intern Med 94:482-484
16. Kawanami O, Jin E, Ghazizadeh M, Fujiwara M, Jiang L, Nagashima M, Shimizu H, et al. (2000) Heterogeneous distribution of thrombomodulin and von Willebrand factor in endothelial cells in the human pulmonary microvessels. J Nippon Med Sch 67:118-125
17. Kinjo T, Takashi M, Miyake K, Nagura H (1989) Phenotypic heterogeneity of vascular endothelial cells in the human kidney. Cell Tissue Res 256:27-34
18. Korkusuz P, Dagdeviren A, Asan E (2002) Immunophenotypic analysis of human spleen compartments. Ann Anat 184:431-441
19. Kutzner H (1993) Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue. J Am Acad Dermatol 28:613-617
20. Lopez AA, Maeda NY (1998) Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension. Chest 114:1276-1282
21. Lufkin EG, Fass DN, O'Fallon WM, Bowie EJ (1979) Increased von Willebrand factor in diabetes mellitus. Metabolism 28:63-66
22. Matsumura T, Wol K, Petzelbauer P (1997) Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 158:3408-3416
23. McKenney JK, Weiss SW, Folpe AL (2001) CD31 expression in intratumoral macrophages: a potential diagnostic pitfall. Am J Surg Pathol 25:1167-1173
24. Miettinen M, Lindenmayer AE, Chaubal A (1994) Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82-90
25. Müller AM, Hermanns MI, Skrzynski C, Nesslinger M, Müller KM, Kirppatrick J (2002a) Expression of the endothelial markers PECAM-1, VWf and CD34 in vivo and in vitro. Exp Mol Pathol 72:221-229
26. Müller AM, Skrzynski C, Nesslinger M, Skipka G, Müller KM (2002b) Correlation of age with in vivo expression of endothelial markers. Exp Gerontol 37:713-719
27. Müller AM, Skrzynski C, Skipka G, Muller KM (2002c) Expression of von Willebrand factor by human pulmonary endothelial cells in vivo. Respiration (Herrlisheim) 69:526-533
28. Ordonez NG (2005) D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma. Hum Pathol 36:372-380
29. Ordonez NG (In Press) The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study. Mod Pathol. Published online July 29, 2005 (DOI: 10.1038/modpathol.3800471)
30. Poblet E, Gonzalez-Palacios F, Jimenez FJ (1996) Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas. Virchows Arch 428:217-221
31. Rand JH, Badimon L, Gordon RE, Uson RR, Fuster V (1987) Distribution of von Willebrand factor in porcine intima varies with blood vessel type and location. Arteriosclerosis 7:287-291
32. Rand JH, Patel ND, Schwartz E, Zhou SL, Potter BJ (1991) 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 88:253-259
33. Rossi S, Orvieto E, Furlanetto A, Laurino L, Ninfo V, Dei Tos AP (2004) Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol 17:547-552
34. Ruck P, Xiao JC, Kaiserling E (1995) Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med 119:173-178
35. Smith JM, Meinkoth JH, Hochstatter T, Meyers KM (1996) Differential distribution of von Willebrand factor in canine vascular endothelium. Am J Vet Res 57:750-755
36. Warhol MJ, Sweet JM (1984) The ultra structural localization of von Willebrand factor in endothelial cells. Am J Pathol 117:310-315
37. Weiss HJ (1991) von Willebrand factor and platelet function. Ann NY Acad Sci 614:125-137
38. Westra WH, Gerald WL, Rosai J (1994) Solitary fibrous tumor. Consistent CD34 immunoreactivity and occurrence in the orbit. Am J Pathol 18:992-998
39. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ (1998) Tissue distribution of von Willebrand factor gene expression in vivo. Blood 92:2791-2801
40. Yamamoto M, Shimokata K, Nagura H (1988) An immunohistochemical study on phenotypic heterogeneity of human pulmonary vascular endothelial cells. Virchows Arch A Pathol Anat Histopathol 412:479-486
41. Zhou Z, Christofidou-Solomidou M, Garlanda C, DeLisser HM (1999) Antibody against murine PECAM-1 inhibits tumor angiogenesis in mice. Angiogenesis 3:181-188